$Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation$

Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation

Aim of investigation. To estimate effect of biofeedback-therapy (BFT) on clinical symptoms, quality of life, sensorimotor function of anorectal area at irritable bowel syndrome (IBS) with refractory constipation (IBS-C).Material and methods. Overall 38 patients with IBS-C (according to Rome III crit...

Full description

Saved in:

Bibliographic Details
Main Author:	O. V. Krapivnaya
Format:	Article
Language:	Russian
Published:	Gastro LLC 2014-07-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	irritable bowel syndrome biofeedbacktherapy anorectal manometry
Online Access:	https://www.gastro-j.ru/jour/article/view/1086
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diagnosis of Functional Gastrointestinal Disorders and Choice of Treatment Regimen in Constipation Patients
by: I. V. Maev, et al.
Published: (2021-10-01)

Effect of combined therapy by pinaverium bromide and itopride hydrochloride on clinical semiology and quality of life of patients with combination of constipation variant of irritable bowel syndrome and functional dyspepsia
by: O. V. Krapivnaya, et al.
Published: (2015-05-01)

Discussion of the problem of functional constipation and irritable bowel syndrome in the reports of the International Congress on Neurogastroenterology and Motility (Bologna, 2012)
by: A. A. Sheptulin, et al.
Published: (2013-03-01)

Combination of functional dyspepsia syndrome and irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2011-06-01)

Clinical value of motor function of digestive system investigation: past, present and future
by: A. S. Trukhmanov, et al.
Published: (2013-10-01)

Postinfectious Irritable Bowel Syndrome: Polemic and Open Issues
by: A. A. Sheptulin, et al.
Published: (2022-03-01)

Acetylcholine in irritable bowel syndrome pathogenesis and the role of cholineblockers
by: Yu. O. Shulpekova
Published: (2011-02-01)

Use of Bismuth in Irritable Bowel Syndrome
by: T. A. Ilchishina
Published: (2021-10-01)

Irritable Bowel Syndrome in Terms of Changes in the Microbiota
by: Vladimir T. Ivashkin, et al.
Published: (2019-03-01)

Features of nervous system in children with irritable bowel syndrome
by: O. K. Botvin’yev, et al.
Published: (2011-12-01)

Irritable Bowel Syndrome Diagnosis: Should There Be Alertness to Cancer?
by: A. A. Sheptulin, et al.
Published: (2019-05-01)

Inflammatory Bowel Diseases and Irritable Bowel Syndrome: Overlap of Two Nosological Forms or Two Variants of the Same Disease?
by: A. A. Sheptulin, et al.
Published: (2019-12-01)

Single Nucleotide Polymorphisms, Associated with Increased Risk of Irritable Bowel Syndrome with Predominant Constipation: A Meta Analysis
by: E. A. Trush, et al.
Published: (2024-08-01)

Diagnosis and Treatment of Irritable Bowel Syndrome: Clinical Recommendations of the Russian Gastroenterological Association and Association of Coloproctologists of Russia
by: V. T. Ivashkin, et al.
Published: (2022-01-01)

The treatment of irritable bowel syndrome from the modern views on the disease pathogenesis
by: Ye. A. Poluektova, et al.
Published: (2013-03-01)

Pathogenetic Substantiation of the Therapeutic Impact on Microbiota in Irritable Bowel Syndrome
by: Yu. O. Shulpekova, et al.
Published: (2019-09-01)

Role of nutritional factors at the irritable bowel syndrome
by: Yu. O. Shulpekova, et al.
Published: (2015-10-01)

COVID-19 Pandemic and Irritable Bowel Syndrome — is there a Relationship?
by: V. A. Akhmedov
Published: (2022-08-01)

Interrelation of irritable bowel syndrome and bacterial overgrowth: is there any?
by: Yu. A. Kucheryavy, et al.
Published: (2014-08-01)

Discussion of irritable bowel syndrome issue and functional constipations in reports of the 21st United European Gastroenterological Week (Berlin, 2013)
by: A. A. Sheptulin, et al.
Published: (2014-09-01)

Esophageal lesions at irritable bowel syndrome
by: M. G. Mnatsakanyan, et al.
Published: (2015-10-01)

A Multimodal Approach to Analgesia in Anorectal Surgery
by: T. N. Garmanova, et al.
Published: (2023-06-01)

Irritable Bowel Syndrome Onset after New Coronavirus Infection COVID-19
by: I. Yu. Feklina, et al.
Published: (2022-03-01)

Bowel diseases and constipation in practice of the obstetrician and gynecologist
by: I. V. Kuznetsova, et al.
Published: (2015-03-01)

Issues of diagnostics and treatment of abdominal pain at irritable bowel syndrome at outpatient stage of the healthcare
by: Yu. A. Kucheryavy, et al.
Published: (2015-12-01)

Experience in the Treatment of Irritable Bowel Syndrome Developed after a New Coronavirus Infection (COVID-19)
by: R. G. Myazin
Published: (2022-05-01)

Combined alverine citrate and simeticonein preparation in the treatment of irritable bowel syndrome
by: Ye. A. Poluektova, et al.
Published: (2012-07-01)

Irritable bowel syndrome: pathophysiological and clinical issues
by: V. T. Ivashkin, et al.
Published: (2015-03-01)

Pathogenic role of intestinal microflora changes in patients with irritable bowel syndrome and treatment options
by: Ye. A. Poluektova, et al.
Published: (2014-09-01)

Comparative efficacy of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> composition and prucalopride in treatment of constipation variant of irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2015-07-01)

Management of a Female Patient with Irritable Bowel Syndrome and Somatoform Disorder
by: E. A. Trush, et al.
Published: (2023-02-01)

Irritable Bowel Syndrome: What Are the Reasons for Dissatisfaction with the Treatment of Patients and Doctors? (Based on the Experience of Medical Institutions of the Northwestern Federal District of Russia)
by: A. Yu. Baranovsky, et al.
Published: (2024-01-01)

Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Irritable Bowel Syndrome who Have Suffered COVID-19
by: A. V. Nalyotov, et al.
Published: (2022-09-01)

Irritable Bowel and Bacterial Overgrowth Syndromes: a Bacterial Link Hypothesis of Functional Disease
by: K. V. Ivashkin, et al.
Published: (2021-04-01)

Eating Habits, Anxiety and Depression in Patients with Irritable Bowel Syndrome: Clinical and Laboratory Comparisons
by: O. V. Gaus, et al.
Published: (2023-08-01)

Role of emotional disorders, personality features and disorders of intraceptive sensation in development of somatic symptoms at irritable bowel syndrome
by: Ye. A. Poluektova, et al.
Published: (2013-12-01)

Quality of Life and Level of Physical Activity In Students with and without Symptoms of Functional Dyspepsia and Irritable Bowel Syndrome Surveyed with Questionnaire “7×7” (7 Symptoms Per 7 Days)
by: T. V. Zhestkova
Published: (2020-07-01)

Comparative assessment of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> and <i>Saccharomyces boulardii</i> efficacy at diarrheal variant of irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2015-05-01)

COVID-19 Pandemic and IBS. Results of the All-Russian Observational Non-interventional Program to Study the Effectiveness of the Drug Kolofort® in Real Clinical Practice in Patients with Irritable Bowel Syndrome After a New Coronavirus Infection (VESNA)
by: V. T. Ivashkin, et al.
Published: (2023-12-01)

Determination of Probiotics Prescription Indications in Patients with Irritable Bowel Syndrome (Materials of the Expert Council and Literature Review)
by: V. T. Ivashkin, et al.
Published: (2022-08-01)